Zacks Company Profile for Fulgent Genetics, Inc. (FLGT : NSDQ) |
|
|
|
Company Description |
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Number of Employees: 1,313 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $20.06 |
Daily Weekly Monthly
 |
20 Day Moving Average: 190,682 shares |
Shares Outstanding: 30.44 (millions) |
Market Capitalization: $610.70 (millions) |
Beta: 1.03 |
52 Week High: $25.11 |
52 Week Low: $14.57 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
-6.39% |
-10.55% |
12 Week |
5.58% |
-9.82% |
Year To Date |
8.61% |
1.73% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Ming Hsieh - Chief Executive Officer and Chairman
Paul Kim - Chief Financial Officer
Michael Nohaile - Director
Regina Groves - Director
Linda Marsh - Director
|
|
Peer Information
Fulgent Genetics, Inc. (HLIS)
Fulgent Genetics, Inc. (AZTA)
Fulgent Genetics, Inc. (APYI)
Fulgent Genetics, Inc. (RNVA)
Fulgent Genetics, Inc. (HMSY)
Fulgent Genetics, Inc. (LRSI)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 359664109
SIC: 8071
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/01/25
|
|
Share - Related Items
Shares Outstanding: 30.44
Most Recent Split Date: (:1)
Beta: 1.03
Market Capitalization: $610.70 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $-0.53 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $-1.91 |
Payout Ratio: |
Number of Estimates in the Fiscal Year Consensus: 2.00 |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/01/25 |
|
|
|
|